HCA Healthcare, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by HCA Healthcare, Inc. on February 21, 2025, regarding events occurring on February 18, 2025. The filing details the completion of a public offering of senior notes by HCA Inc., a direct, wholly owned subsidiary of HCA Healthcare, Inc.
Key Financial Metrics and Debt Issuance
The company completed the issuance of $5.25 billion in aggregate principal amount of senior notes. The notes are guaranteed on a senior unsecured basis by the Parent Guarantor. The specific tranches issued are as follows:
- 2028 Notes: $700 million at 5.000% fixed interest.
- Floating Rate Notes (2028): $300 million with floating interest rates.
- 2030 Notes: $750 million at 5.250% fixed interest.
- 2032 Notes: $750 million at 5.500% fixed interest.
- 2035 Notes: $1.5 billion at 5.750% fixed interest.
- 2055 Notes: $1.25 billion at 6.200% fixed interest.
Interest payments on fixed-rate notes commence September 1, 2025, while floating-rate interest payments commence June 1, 2025. The filing does not provide specific data on current revenue, profit, cash flow, or existing liquidity positions.
Material Changes and Agreements
The primary material change is the entry into a Material Definitive Agreement (Item 1.01) and the creation of a direct financial obligation (Item 2.03) totaling $5.25 billion. The notes were issued pursuant to an indenture dated August 1, 2011, as amended by six supplemental indentures dated February 21, 2025. The underwriting agreement was entered into on February 18, 2025, with representatives including BofA Securities, Barclays, Citigroup, J.P. Morgan, Mizuho, and Wells Fargo.
Outlook, Risks, and Covenants
The indentures include covenants limiting the Issuer's ability to create liens on certain assets, engage in sale and lease-back transactions, and consolidate or merge. The notes are subject to a change of control provision: upon a qualifying ratings downgrade and a change of control, holders may require the Issuer to repurchase the notes at 101% of the principal amount plus accrued interest. The Issuer retains the right to redeem most tranches (excluding Floating Rate Notes) at specified redemption prices.
Investor Verification Checklist
- Verify the use of proceeds from the $5.25 billion offering in subsequent financial reports.
- Monitor the company's credit ratings to assess the risk of triggering the change of control repurchase provision.
- Review the impact of the new fixed and floating interest obligations on future debt service coverage ratios.
- Confirm the specific terms of the floating rate notes, including the benchmark rate and spread, in the full prospectus supplement.